【24h】

53BP1: a DSB escort

机译:53BP1:DSB护送

获取原文
获取原文并翻译 | 示例
           

摘要

53BP1 is an enigmatic DNA damage response factor that gained prominence because it determines the efficacy of PARP1 inhibitory drugs (PARPi) in BRCA1-deficient cancers. Recent studies have elevated 53BP1 from its modest status of (yet another) DNA damage factor to master regulator of double-strand break (DSB) repair pathway choice. Our review of the literature suggests an alternative view. We propose that 53BP1 has evolved to avoid mutagenic repair outcomes and does so by controlling the processing of DNA ends and the dynamics of DSBs. The consequences of 53BP1 deficiency, such as diminished PARPi efficacy in BRCA1-deficient cells and altered repair of damaged telomeres, can be explained from this viewpoint. We further propose that some of the fidelity functions of 53BP1 coevolved with class switch recombination (CSR) in the immune system. We speculate that, rather than being deterministic in DSB repair pathway choice, 53BP1 functions as a DSB escort that guards against illegitimate and potentially tumorigenic recombination.
机译:53bp1是一种神秘的DNA损伤响应因素,其获得突出,因为它决定了PARP1抑制药物(PARPI)在BRCA1缺陷癌症中的功效。最近的研究升高了53bp1从其适度的(又一个)DNA损伤因子到双链休息(DSB)修复途径选择的校长调节因子。我们对文献的审查表明了另一种观点。我们提出53bp1已经进化,以避免诱变修复结果,并通过控制DNA结束的处理和DSB的动态来实现。可以从这个观点解释53bp1缺乏的后果,例如在BRCA1缺陷细胞中减少的Parpi疗效和改变受损端粒的修复。我们进一步提出,53BP1的一些保真函数涉及免疫系统中的阶级开关重组(CSR)。我们推测这一点,而不是在DSB修复途径选择中确定,53bp1作为DSB护送的功能,即防止非法和潜在的致瘤重组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号